ACTA1 and myocardial infarction: Treatment with TFR 30, 60, and 120 mg/kg significantly inhibited expression levels of α-SMA, TGF-β1, MMP2, and collagen I (P < 0.05, P < 0.01), which had been significantly upregulated after MI, respectively (P < 0.01).